Newsletter
Supporting Early Stage Immunotherapy Research to Fuel Breakthroughs in Cancer Treatment: Jill O'Donnell-Tormey, Ph.D., CEO & Director of Scientific Affairs, Cancer Research Institute

The Real Chemistry Podcast

Supporting Early Stage Immunotherapy Research to Fuel Breakthroughs in Cancer Treatment: Jill O'Donnell-Tormey, Ph.D., CEO & Director of Scientific Affairs, Cancer Research Institute

Cancer Research Institute is a pioneer in using immunotherapy to treat cancer. This week’s guest, Jill O’Donnell-Tormey, Ph.D., CEO and Director of Scientific Affairs, discusses the future of oncology research,…
October 18, 2018

Supporting Early Stage Immunotherapy Research to Fuel Breakthroughs in Cancer Treatment: Jill O'Donnell-Tormey, Ph.D., CEO & Director of Scientific Affairs, Cancer Research Institute

Cancer Research Institute is a pioneer in using immunotherapy to treat cancer. This week’s guest, Jill O’Donnell-Tormey, Ph.D., CEO and Director of Scientific Affairs, discusses the future of oncology research, the upcoming CRI Awards Gala, what it’s like working alongside a Nobel Prize winner, and her love of baking.

 

You may also like

Subscribe to Health Podcast Network and never miss new Episodes!

Join Our Newsletter

Proudly supported by:

cover
The Lactamo ball supports easier and healthier breastfeeding A specialized ball designed to facilitate and promote breastfeeding.